Amylin Analog Drugs Market Size, Share & Industry Analysis, By Product (Symlin (pramlintide), CagriSema (cagrilintide + semaglutide), and Others), By Disease Indication (Diabetes, Obesity, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, Specialty Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI115425

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Regions
2. Regulatory Scenario, By Key Countries/Regions
3. Pipeline Analysis, By Key Countries/Regions
4. New Product Launches, By Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Eli Lilly and Company
  2. AstraZeneca
  3. F. Hoffmann-La Roche Ltd
  4. AbbVie Inc
  5. Metsera, Inc.
  6. Verdiva Bio Limited
  7. Structure Therapeutics
  8. Eli Lilly and Company
  9. Hangzhou Sciwind Biosciences Co., Ltd
  10. Novo Nordisk A/S

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Diseases, By Key Regions
2. Regulatory Scenario, By Key Countries/Regions
3. Pipeline Analysis, By Key Countries/Regions
4. New Product Launches, By Key Players
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Southeast Asia
  5. Australia
  6. Rest of Asia Pacific
Latin America Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Amylin Analog Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Symlin (pramlintide)
  2. CagriSema (cagrilintide + semaglutide)
  3. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Diabetes
  2. Obesity
  3. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Specialty Pharmacies
  4. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Eli Lilly and Company
  2. AstraZeneca
  3. F. Hoffmann-La Roche Ltd
  4. AbbVie Inc
  5. Metsera, Inc.
  6. Verdiva Bio Limited
  7. Structure Therapeutics
  8. Eli Lilly and Company
  9. Hangzhou Sciwind Biosciences Co., Ltd
  10. Novo Nordisk A/S

Read Less

List of Figures

Figure 1: Global Amylin Analog Drugs Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034

Figure 2: Global Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025 & 2034

Figure 3: Global Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025 & 2034

Figure 4: Global Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025 & 2034

Figure 5: Global Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 6: Global Amylin Analog Drugs Market Value Share (%), by Region, 2025 & 2034

Figure 7: North America Amylin Analog Drugs Market Value (USD million),2034 by Product, 2025 & 2034

Figure 8: North America Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025

Figure 9: North America Amylin Analog Drugs Market Value (USD million), by Disease Indication, 2025 & 2034

Figure 10: North America Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025

Figure 11: North America Amylin Analog Drugs Market Value (USD million), by Route of Administration 2025 & 2034

Figure 12: North America Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025

Figure 13: North America Amylin Analog Drugs Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 14: North America Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 15: North America Amylin Analog Drugs Market Value (USD million), by Country, 2025 & 2034

Figure 16: North America Amylin Analog Drugs Market Value Share (%), by Country, 2025

Figure 17: Europe Amylin Analog Drugs Market Value (USD million),2034 by Product, 2025 & 2034

Figure 18: Europe Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025

Figure 19: Europe Amylin Analog Drugs Market Value (USD million), by Disease Indication, 2025 & 2034

Figure 20: Europe Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025

Figure 21: Europe Amylin Analog Drugs Market Value (USD million), by Route of Administration 2025 & 2034

Figure 22: Europe Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025

Figure 23: Europe Amylin Analog Drugs Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 24: Europe Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 25: Europe Amylin Analog Drugs Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 26: Europe Amylin Analog Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 27: Asia Pacific Amylin Analog Drugs Market Value (USD million),2034 by Product, 2025 & 2034

Figure 28: Asia Pacific Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025

Figure 29: Asia Pacific Amylin Analog Drugs Market Value (USD million), by Disease Indication, 2025 & 2034

Figure 30: Asia Pacific Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025

Figure 31: Asia Pacific Amylin Analog Drugs Market Value (USD million), by Route of Administration 2025 & 2034

Figure 32: Asia Pacific Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025

Figure 33: Asia Pacific Amylin Analog Drugs Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 34: Asia Pacific Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 35: Asia Pacific Amylin Analog Drugs Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 36: Asia Pacific Amylin Analog Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 37: Latin America Amylin Analog Drugs Market Value (USD million),2034 by Product, 2025 & 2034

Figure 38: Latin America Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025

Figure 39: Latin America Amylin Analog Drugs Market Value (USD million), by Disease Indication, 2025 & 2034

Figure 40: Latin America Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025

Figure 41: Latin America Amylin Analog Drugs Market Value (USD million), by Route of Administration 2025 & 2034

Figure 42: Latin America Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025

Figure 43: Latin America Amylin Analog Drugs Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 44: Latin America Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 45: Latin America Amylin Analog Drugs Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 46: Latin America Amylin Analog Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 47: Middle East & Africa Amylin Analog Drugs Market Value (USD million),2034 by Product, 2025 & 2034

Figure 48: Middle East & Africa Amylin Analog Drugs Market Value Share (%),2034 by Product, 2025

Figure 49: Middle East & Africa Amylin Analog Drugs Market Value (USD million), by Disease Indication, 2025 & 2034

Figure 50: Middle East & Africa Amylin Analog Drugs Market Value Share (%), by Disease Indication, 2025

Figure 51: Middle East & Africa Amylin Analog Drugs Market Value (USD million), by Route of Administration 2025 & 2034

Figure 52: Middle East & Africa Amylin Analog Drugs Market Value Share (%), by Route of Administration 2025

Figure 53: Middle East & Africa Amylin Analog Drugs Market Value (USD million), by Distribution Channel, 2025 & 2034

Figure 54: Middle East & Africa Amylin Analog Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 55: Middle East & Africa Amylin Analog Drugs Market Value (USD million), by Country/ Sub-region, 2025 & 2034

Figure 56: Middle East & Africa Amylin Analog Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 57: Global Amylin Analog Drugs Market Share (%), by Company, 2025

List of Tables

Table 1: Global Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 2: Global Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 3: Global Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 4: Global Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 5: Global Amylin Analog Drugs Market Revenue (USD million) Forecast, by Region, 2019-2034

Table 6: North America Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 7: North America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 8: North America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 9: North America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 10: North America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Country, 2019-2034

Table 11: Europe Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 12: Europe Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 13: Europe Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 14: Europe Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 15: Europe Amylin Analog Drugs Market Revenue (USD million) Forecast, by Country/ Sub-region, 2019-2034

Table 16: Asia Pacific Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 17: Asia Pacific Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 18: Asia Pacific Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 19: Asia Pacific Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 20: Asia Pacific Amylin Analog Drugs Market Revenue (USD million) Forecast, by Country/ Sub-region, 2019-2034

Table 21: Latin America Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 22: Latin America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 23: Latin America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 24: Latin America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 25: Latin America Amylin Analog Drugs Market Revenue (USD million) Forecast, by Country/ Sub-region, 2019-2034

Table 26: Middle East & Africa Amylin Analog Drugs Market Revenue (USD million) Forecast,2034 by Product, 2021–2034

Table 27: Middle East & Africa Amylin Analog Drugs Market Revenue (USD million) Forecast, by Disease Indication, 2021–2034

Table 28: Middle East & Africa Amylin Analog Drugs Market Revenue (USD million) Forecast, by Route of Administration 2021–2034

Table 29: Middle East & Africa Amylin Analog Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2021–2034

Table 30: Middle East & Africa Amylin Analog Drugs Market Revenue (USD million) Forecast, by Country/ Sub-region, 2019-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 190

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com